Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Tendon & Connective-Tissue Rupture

Strong muscle, brittle tendon, the AAS mismatch

Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
Not applicable (harm documentation)

Reference only. Not medical advice.

What can go wrong

Acute tendon rupture, often requiring surgical repair. Risk compounded by rapid strength gains and heavy training loads.

This is something to take to a clinician. The Atlas can tell you what is known about tendon & connective-tissue rupture in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

Anabolic steroids are associated with tendon and connective-tissue injury. The proposed mechanism is a mismatch: AAS rapidly increase muscle mass and contractile force, but tendon collagen adapts more slowly and animal studies suggest AAS may alter collagen architecture (stiffer, less elastic, more prone to rupture). Reports of pectoralis, biceps, and quadriceps tendon ruptures in AAS-using lifters are common, though high-quality human evidence is limited and confounded by the heavier loads these users lift. The practical point: the muscle can generate force the tendon is not ready for.

Tendons may not keep up with the muscle steroids build.

What people take it for

These are the reasons people give for taking it. They are not effects it has been shown to have.

  • Documents connective-tissue risk in AAS users

Replacement is not the same as a cycle

Concern relates to supraphysiological androgen use enabling muscle force that outpaces tendon adaptation.

What people get wrong

  • Often saidSteroids strengthen everything equally

    ActuallyMuscle adapts fast; tendon collagen lags and may be altered by AAS, creating a force-versus-strength mismatch that predisposes to rupture.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

At a glance

Mechanism
Muscle force outpaces tendon adaptation
Common sites
Pectoralis, biceps, quadriceps tendons
Evidence
Animal data + clinical reports; human RCTs lacking

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Tendon & Connective-Tissue Rupture. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.
  • Where we land. We have not taken a position on this yet.

Sources

No sources recorded for this entry yet. Nothing on this page can be checked against a citation until that changes, so treat it as a summary awaiting its evidence.